study_name	subject_id	Sample Source ID	target_condition	target_condition_ontology_term_id	control	control_ontology_term_id	country	country_ontology_term_id	body_site	body_site_ontology_term_id	age_group	age_group_ontology_term_id	age_max	age_min	age_years	antibiotics_current_use	biomarker	bmi	curator	disease	disease_ontology_term_id	median_read_length	minimum_read_length	ncbi_accession	number_bases	number_reads	pmid	sequencing_platform	sex	sex_ontology_term_id	treatment	treatment_ontology_term_id	westernized	package	last_updated
KarlssonFH_2013	S112	S112	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:22.2<;>C-peptide_in_ng/ml:1.83183<;>Cholesterol_in_mg/dL:202.2428448<;>Creatinine_in_umol/L:65<;>Fibroblast_Growth_Factor_19_in_pg/ml:115.77<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:142.3422<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:38.27625652224<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.15<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:31.69752493248<;>Leptin_in_ug/L:12.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:932.26<;>Triglyceride_in_mg/dL:95.70894677384	24.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260249	1954234860	19348860	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S118	S118	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:12.3<;>C-peptide_in_ng/ml:1.53153<;>Cholesterol_in_mg/dL:212.2969824<;>Creatinine_in_umol/L:74<;>Fibroblast_Growth_Factor_19_in_pg/ml:108.38<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.1847446504<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.16<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:57.86293466448<;>Leptin_in_ug/L:23<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:522.14<;>Triglyceride_in_mg/dL:47.85447338692	32.7	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260250	3307295096	32745496	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S121	S121	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:12.2<;>C-peptide_in_ng/ml:2.7027<;>Cholesterol_in_mg/dL:200.3093568<;>Creatinine_in_umol/L:68<;>Fibroblast_Growth_Factor_19_in_pg/ml:156.83<;>Glucagon-like_Peptide-1_in_pmol/L:0.8<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:42.16368882528<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.13<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:31.54800830544<;>Leptin_in_ug/L:72.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:767.02<;>Triglyceride_in_mg/dL:43.1474760046	29.7	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260251	2503143600	24783600	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S126	S126	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:15.6<;>C-peptide_in_ng/ml:1.5015<;>Cholesterol_in_mg/dL:257.9272992<;>Creatinine_in_umol/L:63<;>Fibroblast_Growth_Factor_19_in_pg/ml:100.46<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:81.081<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:40.66852255488<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.39<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:52.330819464<;>Leptin_in_ug/L:4.75<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:806.45<;>Triglyceride_in_mg/dL:77.66545680828	18.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260252	2981401426	29518826	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S127	S127	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.7<;>C-peptide_in_ng/ml:3.42342<;>Cholesterol_in_mg/dL:235.4988384<;>Creatinine_in_umol/L:114<;>Glucose_in_mg/dL:113.5134<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.9323277856<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.68<;>LDL_Particles_in_mg/dL:62.34843347568<;>Leptin_in_ug/L:25.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Triglyceride_in_mg/dL:90.2174498278	26.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260253	2480018034	24554634	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S131	S131	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:7<;>C-peptide_in_ng/ml:5.34534<;>Cholesterol_in_mg/dL:181.747872<;>Creatinine_in_umol/L:71<;>Fibroblast_Growth_Factor_19_in_pg/ml:147.82<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.6992458392<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:26.51<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:41.8646555712<;>Leptin_in_ug/L:29.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1107.28<;>Triglyceride_in_mg/dL:148.27041754308	26.5	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260254	2607637392	25818192	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S137	S137	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:17.4<;>C-peptide_in_ng/ml:2.16216<;>Cholesterol_in_mg/dL:294.6635712<;>Creatinine_in_umol/L:58<;>Fibroblast_Growth_Factor_19_in_pg/ml:122.88<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:90.09<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.04317457584<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.82<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:74.60879689296<;>Leptin_in_ug/L:11.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:637.54<;>Triglyceride_in_mg/dL:72.17395986224	23.2	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	96	96	ERR260268	797799936	8310416	23719380	IlluminaHiSeq	Female	NCIT:C16576	NA	NA	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S141	S141	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:21.4<;>C-peptide_in_ng/ml:1.32132<;>Cholesterol_in_mg/dL:186.7749408<;>Creatinine_in_umol/L:75<;>Fibroblast_Growth_Factor_19_in_pg/ml:33.33<;>Glucagon-like_Peptide-1_in_pmol/L:0.8<;>Glucose_in_mg/dL:82.8828<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:38.27625652224<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.9<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:29.45477552688<;>Leptin_in_ug/L:8.96<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:710.69<;>Triglyceride_in_mg/dL:52.56147076924	25.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260255	1999859186	19800586	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S143	S143	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:12.3<;>C-peptide_in_ng/ml:2.37237<;>Cholesterol_in_mg/dL:233.5653504<;>Creatinine_in_umol/L:71<;>Fibroblast_Growth_Factor_19_in_pg/ml:172.94<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:88.2882<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.94027433808<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.56<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:47.0977375176<;>Leptin_in_ug/L:22.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:814.43<;>Triglyceride_in_mg/dL:106.69194066592	28.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260256	3014347020	29845020	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S144	S144	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:16.4<;>C-peptide_in_ng/ml:1.92192<;>Cholesterol_in_mg/dL:237.4323264<;>Creatinine_in_umol/L:94<;>Fibroblast_Growth_Factor_19_in_pg/ml:91.32<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:29.903325408<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.27<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:55.02211875072<;>Leptin_in_ug/L:14.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:810.44<;>Triglyceride_in_mg/dL:79.23445593572	24	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260257	4552459456	45073856	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S146	S146	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:21.1<;>C-peptide_in_ng/ml:1.68168<;>Cholesterol_in_mg/dL:250.1933472<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:85.29<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:81.081<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.48377790448<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.68<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:68.47861518432<;>Leptin_in_ug/L:42.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:918.41<;>Triglyceride_in_mg/dL:91.78644895524	36.9	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260258	2389231154	23655754	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S153	S153	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:27.6<;>C-peptide_in_ng/ml:1.47147<;>Cholesterol_in_mg/dL:266.0479488<;>Creatinine_in_umol/L:63<;>Fibroblast_Growth_Factor_19_in_pg/ml:66.99<;>Glucagon-like_Peptide-1_in_pmol/L:0.4<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:37.82770664112<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.5<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:62.19891684864<;>Leptin_in_ug/L:6.16<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:639.78<;>Triglyceride_in_mg/dL:32.94898167624	21.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260259	3929291476	38903876	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S155	S155	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	France	NCIT:C16592	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:16.5<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:215.0038656<;>Creatinine_in_umol/L:62<;>Fibroblast_Growth_Factor_19_in_pg/ml:131.88<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:90.09<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:35.1364073544<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.6<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.31320545232<;>Leptin_in_ug/L:8.49<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:476.37<;>Triglyceride_in_mg/dL:65.11346378876	21.5	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260260	3874689260	38363260	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S158	S158	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	68	68	68	No	Adiponectin_in_ug/mL:10.5<;>C-peptide_in_ng/ml:8.1081<;>Cholesterol_in_mg/dL:203.4029376<;>Creatinine_in_umol/L:97<;>Fibroblast_Growth_Factor_19_in_pg/ml:56.02<;>Glucagon-like_Peptide-1_in_pmol/L:4.8<;>Glucose_in_mg/dL:198.198<;>Glycosylated_Hemoglobin_in_mmol/mol:116.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.55767576464<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:6.48<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:40.07045604672<;>Leptin_in_ug/L:33.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1073.95<;>Triglyceride_in_mg/dL:117.674934558	31.2	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260261	4053706508	40135708	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S186	S186	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:20.1<;>C-peptide_in_ng/ml:1.65165<;>Cholesterol_in_mg/dL:204.5630304<;>Creatinine_in_umol/L:52<;>Fibroblast_Growth_Factor_19_in_pg/ml:172.68<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.19269120288<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.51<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:41.8646555712<;>Leptin_in_ug/L:11.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:608.62<;>Triglyceride_in_mg/dL:47.0699738232	23.6	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260262	2995481028	29658228	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S187	S187	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:10.1<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:245.552976<;>Creatinine_in_umol/L:85<;>Fibroblast_Growth_Factor_19_in_pg/ml:73.53<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.01589310496<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.26<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:60.85326720528<;>Leptin_in_ug/L:28.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:817.84<;>Triglyceride_in_mg/dL:92.57094851896	24.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260263	4562815390	45176390	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S193	S193	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.7<;>C-peptide_in_ng/ml:2.49249<;>Cholesterol_in_mg/dL:251.7401376<;>Creatinine_in_umol/L:56<;>Fibroblast_Growth_Factor_19_in_pg/ml:97.98<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:34.3888242192<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.71<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:51.5832363288<;>Leptin_in_ug/L:11.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:603.82<;>Triglyceride_in_mg/dL:131.79592670496	24.2	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260264	4952644484	49036084	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S194	S194	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:14.4<;>C-peptide_in_ng/ml:2.82282<;>Cholesterol_in_mg/dL:160.479504<;>Creatinine_in_umol/L:80<;>Fibroblast_Growth_Factor_19_in_pg/ml:73.58<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.61395961312<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.21<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:29.30525889984<;>Leptin_in_ug/L:15.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:807.93<;>Triglyceride_in_mg/dL:70.6049607348	21.9	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260265	4448436324	44043924	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S195	S195	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:11.4<;>C-peptide_in_ng/ml:1.86186<;>Cholesterol_in_mg/dL:203.01624<;>Creatinine_in_umol/L:71<;>Fibroblast_Growth_Factor_19_in_pg/ml:111.89<;>Glucagon-like_Peptide-1_in_pmol/L:3.4<;>Glucose_in_mg/dL:90.09<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.73619476928<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.84<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:49.78903680432<;>Leptin_in_ug/L:27<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:657.49<;>Triglyceride_in_mg/dL:103.55394241104	28.4	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260266	3926410956	38875356	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S198	S198	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:17.1<;>C-peptide_in_ng/ml:2.61261<;>Cholesterol_in_mg/dL:240.9126048<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:103.25<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:120.7206<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.34220782992<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:52.77936934512<;>Leptin_in_ug/L:18.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1033.03<;>Triglyceride_in_mg/dL:80.01895549944	26.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260267	4078647852	40382652	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S200	S200	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.65<;>C-peptide_in_ng/ml:2.82282<;>Cholesterol_in_mg/dL:197.215776<;>Creatinine_in_umol/L:71<;>Fibroblast_Growth_Factor_19_in_pg/ml:87.99<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:90.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.88571139632<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.52<;>Interleukin_1_in_pg/ml:0.26<;>LDL_Particles_in_mg/dL:42.31320545232<;>Leptin_in_ug/L:23.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:690.19<;>Triglyceride_in_mg/dL:163.17590925376	29.2	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260228	3848483598	38103798	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S205	S205	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.6<;>C-peptide_in_ng/ml:2.73273<;>Cholesterol_in_mg/dL:169.3735488<;>Creatinine_in_umol/L:97<;>Fibroblast_Growth_Factor_19_in_pg/ml:68.8<;>Glucagon-like_Peptide-1_in_pmol/L:3.6<;>Glucose_in_mg/dL:149.5494<;>Glycosylated_Hemoglobin_in_mmol/mol:129.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.32459381824<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.28<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:32.1460748136<;>Leptin_in_ug/L:23.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:676.39<;>Triglyceride_in_mg/dL:117.674934558	24.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260229	2900968460	28722460	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S224	S224	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:11<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:136.5042528<;>Creatinine_in_umol/L:74<;>Fibroblast_Growth_Factor_19_in_pg/ml:49.67<;>Glucagon-like_Peptide-1_in_pmol/L:1.7<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.13812826112<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.03<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:27.21202612128<;>Leptin_in_ug/L:17.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:715.62<;>Triglyceride_in_mg/dL:75.31195811712	26.5	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260230	1996491240	19767240	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S225	S225	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11<;>C-peptide_in_ng/ml:2.43243<;>Cholesterol_in_mg/dL:248.6465568<;>Creatinine_in_umol/L:65<;>Fibroblast_Growth_Factor_19_in_pg/ml:58.24<;>Glucagon-like_Peptide-1_in_pmol/L:0.2<;>Glucose_in_mg/dL:113.5134<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:31.3984916784<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:13.56<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:60.10568407008<;>Leptin_in_ug/L:14.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:389.8<;>Triglyceride_in_mg/dL:54.13046989668	26.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260231	2099276314	20784914	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S227	S227	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:15.7<;>C-peptide_in_ng/ml:1.74174<;>Cholesterol_in_mg/dL:237.819024<;>Creatinine_in_umol/L:68<;>Fibroblast_Growth_Factor_19_in_pg/ml:297.92<;>Glucagon-like_Peptide-1_in_pmol/L:1.7<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.641241084<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.15<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:52.77936934512<;>Leptin_in_ug/L:30.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:766.81<;>Triglyceride_in_mg/dL:65.89796335248	24	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260232	1885347204	18666804	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S229	S229	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.28<;>C-peptide_in_ng/ml:2.94294<;>Cholesterol_in_mg/dL:254.4470208<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:69.8<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:86.4864<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.02556056416<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:5.67<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:65.7873158976<;>Leptin_in_ug/L:28.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:989.69<;>Triglyceride_in_mg/dL:111.39893804824	27.4	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260233	2088164698	20674898	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S231	S231	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.8<;>C-peptide_in_ng/ml:2.25225<;>Cholesterol_in_mg/dL:235.885536<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:65.28<;>Glucagon-like_Peptide-1_in_pmol/L:0.8<;>Glucose_in_mg/dL:88.2882<;>Glycosylated_Hemoglobin_in_mmol/mol:68.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.21202612128<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.49<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:55.91921851296<;>Leptin_in_ug/L:21.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:592.01<;>Triglyceride_in_mg/dL:94.1399476464	25.7	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260234	2482589292	24580092	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S235	S235	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:8.59<;>C-peptide_in_ng/ml:4.05405<;>Cholesterol_in_mg/dL:194.1221952<;>Creatinine_in_umol/L:110<;>Fibroblast_Growth_Factor_19_in_pg/ml:70.38<;>Glucagon-like_Peptide-1_in_pmol/L:2<;>Glucose_in_mg/dL:201.8016<;>Glycosylated_Hemoglobin_in_mmol/mol:167.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:17.9419952448<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.34<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:30.35187528912<;>Leptin_in_ug/L:57.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:641.53<;>Triglyceride_in_mg/dL:313.799825488	36.4	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260235	1521783362	15067162	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin;Insulin	NCIT:C61612;CHEBI:87631;NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S239	S239	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:16.8<;>C-peptide_in_ng/ml:2.52252<;>Cholesterol_in_mg/dL:257.153904<;>Creatinine_in_umol/L:65<;>Fibroblast_Growth_Factor_19_in_pg/ml:91.03<;>Glucagon-like_Peptide-1_in_pmol/L:1.8<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:18.09151187184<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.36<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:68.32909855728<;>Leptin_in_ug/L:16.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):56.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:699.12<;>Triglyceride_in_mg/dL:152.9774149254	25.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260236	2035785088	20156288	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S243	S243	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.2<;>C-peptide_in_ng/ml:2.34234<;>Cholesterol_in_mg/dL:206.883216<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:125.85<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:111.7116<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:35.1364073544<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:4.11<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:37.22964013296<;>Leptin_in_ug/L:35.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:458.06<;>Triglyceride_in_mg/dL:90.2174498278	26.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260237	2745456134	27182734	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S244	S244	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:10<;>C-peptide_in_ng/ml:6.006<;>Cholesterol_in_mg/dL:274.555296<;>Creatinine_in_umol/L:65<;>Glucose_in_mg/dL:218.0178<;>Glycosylated_Hemoglobin_in_mmol/mol:114.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.84876246624<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:4.64<;>LDL_Particles_in_mg/dL:65.7873158976<;>Leptin_in_ug/L:40.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Triglyceride_in_mg/dL:285.55784119408	32.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260238	2836099796	28080196	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S248	S248	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:6.85<;>C-peptide_in_ng/ml:2.4024<;>Cholesterol_in_mg/dL:206.4965184<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:91.9<;>Glucagon-like_Peptide-1_in_pmol/L:1.5<;>Glucose_in_mg/dL:131.5314<;>Glycosylated_Hemoglobin_in_mmol/mol:105.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.10912588352<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.88<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:43.3598218416<;>Leptin_in_ug/L:48.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:856.49<;>Triglyceride_in_mg/dL:98.84694502872	31.3	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260239	2577105900	25515900	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S249	S249	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:13.5<;>C-peptide_in_ng/ml:2.91291<;>Cholesterol_in_mg/dL:182.9079648<;>Creatinine_in_umol/L:62<;>Fibroblast_Growth_Factor_19_in_pg/ml:76.69<;>Glucagon-like_Peptide-1_in_pmol/L:1.3<;>Glucose_in_mg/dL:88.2882<;>Glycosylated_Hemoglobin_in_mmol/mol:99<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:29.903325408<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.38<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:36.18302374368<;>Leptin_in_ug/L:14.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:704.67<;>Triglyceride_in_mg/dL:54.13046989668	23.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260269	966913152	10072012	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S258	S258	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:8.5<;>C-peptide_in_ng/ml:6.006<;>Cholesterol_in_mg/dL:162.0262944<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:158.27<;>Glucagon-like_Peptide-1_in_pmol/L:7.5<;>Glucose_in_mg/dL:147.7476<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:17.04489548256<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.55<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:32.1460748136<;>Leptin_in_ug/L:45.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:767.49<;>Triglyceride_in_mg/dL:157.68441230772	34.2	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260240	2673502926	26470326	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S263	S263	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:16.2<;>C-peptide_in_ng/ml:1.68168<;>Cholesterol_in_mg/dL:158.9327136<;>Creatinine_in_umol/L:65<;>Fibroblast_Growth_Factor_19_in_pg/ml:123.56<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:93.6936<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.6605760024<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.44<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:27.21202612128<;>Leptin_in_ug/L:8.79<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:635.58<;>Triglyceride_in_mg/dL:76.88095724456	25.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260241	2339488654	23163254	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S264	S264	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:30.2<;>C-peptide_in_ng/ml:1.62162<;>Cholesterol_in_mg/dL:208.4300064<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:146.48<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:90.09<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:31.69752493248<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.63<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:43.3598218416<;>Leptin_in_ug/L:14.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:522.79<;>Triglyceride_in_mg/dL:65.11346378876	24	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260242	1601761828	15859028	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S268	S268	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:15.7<;>C-peptide_in_ng/ml:1.77177<;>Cholesterol_in_mg/dL:247.486464<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:75.4<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:29.00622564576<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.94<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:60.40471732416<;>Leptin_in_ug/L:7.33<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:552.14<;>Triglyceride_in_mg/dL:72.95845942596	25.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260243	2297022396	22742796	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S269	S269	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:13.1<;>C-peptide_in_ng/ml:1.83183<;>Cholesterol_in_mg/dL:221.5777248<;>Creatinine_in_umol/L:58<;>Fibroblast_Growth_Factor_19_in_pg/ml:149.89<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:37.22964013296<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.12<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.31320545232<;>Leptin_in_ug/L:39.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:766.32<;>Triglyceride_in_mg/dL:72.95845942596	32.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260244	1939606828	19204028	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S278	S278	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Norway	NCIT:C16920	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:14.1<;>C-peptide_in_ng/ml:2.43243<;>Cholesterol_in_mg/dL:259.8607872<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:90.97<;>Glucagon-like_Peptide-1_in_pmol/L:0.8<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.36154274832<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.05<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:68.32909855728<;>Leptin_in_ug/L:44.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:745.27<;>Triglyceride_in_mg/dL:55.69946902412	33.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260245	2711037556	26841956	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S286	S286	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Denmark	NCIT:C16496	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.34<;>C-peptide_in_ng/ml:2.37237<;>Cholesterol_in_mg/dL:185.614848<;>Creatinine_in_umol/L:54<;>Fibroblast_Growth_Factor_19_in_pg/ml:36.12<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:192.7926<;>Glycosylated_Hemoglobin_in_mmol/mol:101.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.55767576464<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.82<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:36.78109025184<;>Leptin_in_ug/L:19.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:683.31<;>Triglyceride_in_mg/dL:73.74295898968	23	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260270	1061488704	11057174	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S288	S288	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:20.5<;>C-peptide_in_ng/ml:1.89189<;>Cholesterol_in_mg/dL:170.146944<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:114.86<;>Glucagon-like_Peptide-1_in_pmol/L:0.8<;>Glucose_in_mg/dL:120.7206<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.63329453152<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.24<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:37.52867338704<;>Leptin_in_ug/L:8.53<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:602.49<;>Triglyceride_in_mg/dL:89.43295026408	26.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260246	2489746758	24650958	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S290	S290	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:10.1<;>C-peptide_in_ng/ml:2.67267<;>Cholesterol_in_mg/dL:220.8043296<;>Creatinine_in_umol/L:77<;>Fibroblast_Growth_Factor_19_in_pg/ml:455.48<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:109.9098<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.97894417488<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.26<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:47.69580402576<;>Leptin_in_ug/L:20.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:702.19<;>Triglyceride_in_mg/dL:183.57289791048	23.8	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260247	2351107088	23278288	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S297	S297	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:15.1<;>C-peptide_in_ng/ml:2.22222<;>Cholesterol_in_mg/dL:272.621808<;>Creatinine_in_umol/L:65<;>Fibroblast_Growth_Factor_19_in_pg/ml:50.89<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:108.108<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.20235866208<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.54<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:69.37571494656<;>Leptin_in_ug/L:10.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:765.46<;>Triglyceride_in_mg/dL:66.6824629162	22	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260271	761805504	7935474	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S299	S299	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:10.9<;>C-peptide_in_ng/ml:3.54354<;>Cholesterol_in_mg/dL:271.0750176<;>Creatinine_in_umol/L:70<;>Fibroblast_Growth_Factor_19_in_pg/ml:172.12<;>Glucagon-like_Peptide-1_in_pmol/L:11.2<;>Glucose_in_mg/dL:82.8828<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.23136103968<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.67<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:71.91749760624<;>Leptin_in_ug/L:19.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:839.61<;>Triglyceride_in_mg/dL:135.71842452356	26.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260248	2282760388	22601588	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S304	S304	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.5<;>C-peptide_in_ng/ml:2.04204<;>Cholesterol_in_mg/dL:164.34648<;>Creatinine_in_umol/L:57<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.1750771912<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.49<;>LDL_Particles_in_mg/dL:34.3888242192<;>Leptin_in_ug/L:21.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):3<;>Triglyceride_in_mg/dL:70.6049607348	29.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260132	2756179910	27288910	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S305	S305	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:20.7<;>C-peptide_in_ng/ml:1.83183<;>Cholesterol_in_mg/dL:242.8460928<;>Creatinine_in_umol/L:54<;>Fibroblast_Growth_Factor_19_in_pg/ml:202.04<;>Glucagon-like_Peptide-1_in_pmol/L:1.6<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:90.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.31492635904<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.13<;>Interleukin_1_in_pg/ml:4.64<;>LDL_Particles_in_mg/dL:58.46100117264<;>Leptin_in_ug/L:7.01<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:617.9<;>Triglyceride_in_mg/dL:106.69194066592	21.5	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260133	2664136590	26377590	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S312	S312	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:23.3<;>C-peptide_in_ng/ml:2.13213<;>Cholesterol_in_mg/dL:203.01624<;>Creatinine_in_umol/L:73<;>Fibroblast_Growth_Factor_19_in_pg/ml:79.48<;>Glucagon-like_Peptide-1_in_pmol/L:0.4<;>Glucose_in_mg/dL:122.5224<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:34.98689072736<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.14<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:37.22964013296<;>Leptin_in_ug/L:36<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:688.31<;>Triglyceride_in_mg/dL:72.95845942596	26.7	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260134	14947398242	147994042	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S317	S317	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:13.2<;>C-peptide_in_ng/ml:2.52252<;>Cholesterol_in_mg/dL:221.5777248<;>Creatinine_in_umol/L:92<;>Fibroblast_Growth_Factor_19_in_pg/ml:260.83<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:108.108<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:36.78109025184<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.83<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:45.15402136608<;>Leptin_in_ug/L:28<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:501.25<;>Triglyceride_in_mg/dL:42.36297644088	26	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260135	13981314860	138428860	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S327	S327	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.6<;>C-peptide_in_ng/ml:2.31231<;>Cholesterol_in_mg/dL:249.419952<;>Creatinine_in_umol/L:76<;>Fibroblast_Growth_Factor_19_in_pg/ml:77.77<;>Glucagon-like_Peptide-1_in_pmol/L:0<;>Glucose_in_mg/dL:91.8918<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:34.98689072736<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.49<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:54.5735688696<;>Leptin_in_ug/L:38.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:889.07<;>Triglyceride_in_mg/dL:80.80345506316	30.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260136	2589449312	25638112	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S330	S330	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.3<;>C-peptide_in_ng/ml:2.76276<;>Cholesterol_in_mg/dL:173.2405248<;>Creatinine_in_umol/L:182<;>Fibroblast_Growth_Factor_19_in_pg/ml:98.57<;>Glucagon-like_Peptide-1_in_pmol/L:0.5<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:32.59462469472<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.26<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:27.06250949424<;>Leptin_in_ug/L:37.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:894.24<;>Triglyceride_in_mg/dL:85.51045244548	29.6	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260137	1942446342	19232142	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S332	S332	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:24.6<;>C-peptide_in_ng/ml:4.05405<;>Cholesterol_in_mg/dL:250.5800448<;>Creatinine_in_umol/L:112<;>Fibroblast_Growth_Factor_19_in_pg/ml:344.52<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:124.3242<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:42.6122387064<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:5.68<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:47.8453206528<;>Leptin_in_ug/L:57.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:894.44<;>Triglyceride_in_mg/dL:74.5274585534	29.2	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260138	3430913238	33969438	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S334	S334	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.54<;>C-peptide_in_ng/ml:3.66366<;>Cholesterol_in_mg/dL:147.7184832<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:82.53<;>Glucagon-like_Peptide-1_in_pmol/L:1.3<;>Glucose_in_mg/dL:120.7206<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.1847446504<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.07<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:27.95960925648<;>Leptin_in_ug/L:7.02<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):4.7<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:276.65<;>Triglyceride_in_mg/dL:105.9074411022	25.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260139	2036676514	20165114	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S342	S342	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:20.6<;>C-peptide_in_ng/ml:2.13213<;>Cholesterol_in_mg/dL:225.0580032<;>Creatinine_in_umol/L:67<;>Fibroblast_Growth_Factor_19_in_pg/ml:125.01<;>Glucagon-like_Peptide-1_in_pmol/L:0.5<;>Glucose_in_mg/dL:115.3152<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:31.99655818656<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.69<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:49.78903680432<;>Leptin_in_ug/L:6.21<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:564.43<;>Triglyceride_in_mg/dL:61.19096597016	22.3	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260272	789010752	8218862	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S344	S344	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:6.75<;>C-peptide_in_ng/ml:5.52552<;>Cholesterol_in_mg/dL:225.8313984<;>Creatinine_in_umol/L:85<;>Fibroblast_Growth_Factor_19_in_pg/ml:138.55<;>Glucagon-like_Peptide-1_in_pmol/L:0.6<;>Glucose_in_mg/dL:84.6846<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:17.79247861776<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:11.37<;>Interleukin_1_in_pg/ml:2.41<;>LDL_Particles_in_mg/dL:59.20858430784<;>Leptin_in_ug/L:105<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1004<;>Triglyceride_in_mg/dL:120.81293281288	41.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260140	1935856900	19166900	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S347	S347	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:13<;>C-peptide_in_ng/ml:2.22222<;>Cholesterol_in_mg/dL:201.082752<;>Creatinine_in_umol/L:63<;>Fibroblast_Growth_Factor_19_in_pg/ml:202.14<;>Glucagon-like_Peptide-1_in_pmol/L:1<;>Glucose_in_mg/dL:97.2972<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:31.54800830544<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.69<;>Interleukin_1_in_pg/ml:0.85<;>LDL_Particles_in_mg/dL:39.6219061656<;>Leptin_in_ug/L:22.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:941.35<;>Triglyceride_in_mg/dL:74.5274585534	24.7	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260141	2488603034	24639634	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S349	S349	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.36<;>C-peptide_in_ng/ml:1.74174<;>Cholesterol_in_mg/dL:174.4006176<;>Creatinine_in_umol/L:48<;>Fibroblast_Growth_Factor_19_in_pg/ml:215.11<;>Glucagon-like_Peptide-1_in_pmol/L:0.6<;>Glucose_in_mg/dL:97.2972<;>Glycosylated_Hemoglobin_in_mmol/mol:59.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.95960925648<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:10.06<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:34.98689072736<;>Leptin_in_ug/L:7.06<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:816.53<;>Triglyceride_in_mg/dL:53.34597033296	19.6	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260142	2452610674	24283274	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S350	S350	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:12.9<;>C-peptide_in_ng/ml:2.07207<;>Cholesterol_in_mg/dL:212.2969824<;>Creatinine_in_umol/L:61<;>Fibroblast_Growth_Factor_19_in_pg/ml:52.1<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:97.2972<;>Glycosylated_Hemoglobin_in_mmol/mol:101.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:32.29559144064<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.42<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.91127196048<;>Leptin_in_ug/L:23.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:559.14<;>Triglyceride_in_mg/dL:80.01895549944	28.2	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260143	2849144956	28209356	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S353	S353	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:26.6<;>C-peptide_in_ng/ml:3.24324<;>Cholesterol_in_mg/dL:218.484144<;>Creatinine_in_umol/L:78<;>Fibroblast_Growth_Factor_19_in_pg/ml:130.04<;>Glucagon-like_Peptide-1_in_pmol/L:2.7<;>Glucose_in_mg/dL:176.5764<;>Glycosylated_Hemoglobin_in_mmol/mol:103.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.53039429376<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.35<;>Interleukin_1_in_pg/ml:6.4<;>LDL_Particles_in_mg/dL:56.06873514<;>Leptin_in_ug/L:36.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:703.12<;>Triglyceride_in_mg/dL:80.01895549944	29.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260144	2483902494	24593094	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S354	S354	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.67<;>C-peptide_in_ng/ml:3.09309<;>Cholesterol_in_mg/dL:224.284608<;>Creatinine_in_umol/L:58<;>Glucose_in_mg/dL:109.9098<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.97894417488<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.85<;>LDL_Particles_in_mg/dL:53.8259857344<;>Leptin_in_ug/L:31.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Triglyceride_in_mg/dL:127.87342888636	32.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260145	2832133728	28040928	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S356	S356	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.13<;>C-peptide_in_ng/ml:2.79279<;>Cholesterol_in_mg/dL:287.7030144<;>Creatinine_in_umol/L:81<;>Fibroblast_Growth_Factor_19_in_pg/ml:61.97<;>Glucagon-like_Peptide-1_in_pmol/L:4<;>Glucose_in_mg/dL:73.8738<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:29.00622564576<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:4.48<;>Interleukin_1_in_pg/ml:1.73<;>LDL_Particles_in_mg/dL:71.16991447104<;>Leptin_in_ug/L:28.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:901.82<;>Triglyceride_in_mg/dL:131.01142714124	27.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260146	2805316612	27775412	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S365	S365	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:16.8<;>C-peptide_in_ng/ml:1.56156<;>Cholesterol_in_mg/dL:218.8708416<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:142.31<;>Glucagon-like_Peptide-1_in_pmol/L:1.5<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:35.73447386256<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.18<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.76175533344<;>Leptin_in_ug/L:23.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:655.19<;>Triglyceride_in_mg/dL:71.38946029852	24.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260147	2821768300	27938300	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S367	S367	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:7.81<;>C-peptide_in_ng/ml:4.56456<;>Cholesterol_in_mg/dL:253.286928<;>Creatinine_in_umol/L:60<;>Glucose_in_mg/dL:70.2702<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:12.11084679024<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:21<;>LDL_Particles_in_mg/dL:43.06078858752<;>Leptin_in_ug/L:42.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Triglyceride_in_mg/dL:498.1572229622	32.3	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260148	2209859194	21879794	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S370	S370	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:7.46<;>C-peptide_in_ng/ml:8.4084<;>Cholesterol_in_mg/dL:195.282288<;>Creatinine_in_umol/L:95<;>Fibroblast_Growth_Factor_19_in_pg/ml:110.08<;>Glucagon-like_Peptide-1_in_pmol/L:13.1<;>Glucose_in_mg/dL:158.5584<;>Glycosylated_Hemoglobin_in_mmol/mol:127.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.10117933104<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.26<;>Interleukin_1_in_pg/ml:0.1<;>LDL_Particles_in_mg/dL:50.8356531936<;>Leptin_in_ug/L:37.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1218.49<;>Triglyceride_in_mg/dL:97.27794590128	28	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260149	3081799264	30512864	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S372	S372	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:14.5<;>C-peptide_in_ng/ml:3.003<;>Cholesterol_in_mg/dL:288.4764096<;>Creatinine_in_umol/L:132<;>Fibroblast_Growth_Factor_19_in_pg/ml:253.72<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.85670901872<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:13.2<;>Interleukin_1_in_pg/ml:0.55<;>LDL_Particles_in_mg/dL:72.21653086032<;>Leptin_in_ug/L:91.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1007.16<;>Triglyceride_in_mg/dL:121.5974323766	39.7	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260150	3043333010	30132010	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S378	S378	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:21.3<;>C-peptide_in_ng/ml:1.2012<;>Cholesterol_in_mg/dL:216.9373536<;>Creatinine_in_umol/L:54<;>Fibroblast_Growth_Factor_19_in_pg/ml:57.14<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:109.9098<;>Glycosylated_Hemoglobin_in_mmol/mol:99<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.61395961312<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.9<;>Interleukin_1_in_pg/ml:9.54<;>LDL_Particles_in_mg/dL:50.38710331248<;>Leptin_in_ug/L:5.47<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:568<;>Triglyceride_in_mg/dL:79.23445593572	21.4	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260151	2630431274	26043874	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S380	S380	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:9.84<;>C-peptide_in_ng/ml:4.2042<;>Cholesterol_in_mg/dL:169.7602464<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:160.61<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:117.117<;>Glycosylated_Hemoglobin_in_mmol/mol:107.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.84876246624<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.84<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:33.79075771104<;>Leptin_in_ug/L:36<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:677.67<;>Triglyceride_in_mg/dL:185.14189703792	30.6	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260152	1813559434	17956034	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S381	S381	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:19.2<;>C-peptide_in_ng/ml:1.77177<;>Cholesterol_in_mg/dL:270.68832<;>Creatinine_in_umol/L:74<;>Fibroblast_Growth_Factor_19_in_pg/ml:97.35<;>Glucagon-like_Peptide-1_in_pmol/L:3.8<;>Glucose_in_mg/dL:73.8738<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:18.54006175296<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.47<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:77.7486460608<;>Leptin_in_ug/L:16.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1216.26<;>Triglyceride_in_mg/dL:98.062445465	25.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260153	2811341262	27835062	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S384	S384	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:5.64<;>C-peptide_in_ng/ml:4.8048<;>Cholesterol_in_mg/dL:161.2528992<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:206.06<;>Glucagon-like_Peptide-1_in_pmol/L:0<;>Glucose_in_mg/dL:138.7386<;>Glycosylated_Hemoglobin_in_mmol/mol:94.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:14.2040795688<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.32<;>Interleukin_1_in_pg/ml:7.29<;>LDL_Particles_in_mg/dL:33.79075771104<;>Leptin_in_ug/L:49.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1231.77<;>Triglyceride_in_mg/dL:168.6674061998	32.8	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260154	2485331038	24607238	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S389	S389	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.55<;>C-peptide_in_ng/ml:3.21321<;>Cholesterol_in_mg/dL:196.0556832<;>Creatinine_in_umol/L:70<;>Fibroblast_Growth_Factor_19_in_pg/ml:30.76<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:140.5404<;>Glycosylated_Hemoglobin_in_mmol/mol:112.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.1750771912<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.65<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:46.64918763648<;>Leptin_in_ug/L:35<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1246.62<;>Triglyceride_in_mg/dL:69.03596160736	27.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260155	2575030956	25495356	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S393	S393	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.4<;>C-peptide_in_ng/ml:3.54354<;>Cholesterol_in_mg/dL:222.35112<;>Creatinine_in_umol/L:85<;>Fibroblast_Growth_Factor_19_in_pg/ml:311.24<;>Glucagon-like_Peptide-1_in_pmol/L:3<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.54972921216<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.84<;>Interleukin_1_in_pg/ml:3.82<;>LDL_Particles_in_mg/dL:47.0977375176<;>Leptin_in_ug/L:26<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:861.83<;>Triglyceride_in_mg/dL:271.43684904712	29.5	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260156	1683913006	16672406	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S395	S395	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.53<;>C-peptide_in_ng/ml:2.67267<;>Cholesterol_in_mg/dL:248.2598592<;>Creatinine_in_umol/L:66<;>Fibroblast_Growth_Factor_19_in_pg/ml:56.69<;>Glucagon-like_Peptide-1_in_pmol/L:0.6<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:22.427494056<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.41<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:65.18924938944<;>Leptin_in_ug/L:19.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):2.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:811<;>Triglyceride_in_mg/dL:97.27794590128	30.4	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260157	2355739554	23324154	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S397	S397	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:7.67<;>C-peptide_in_ng/ml:2.16216<;>Cholesterol_in_mg/dL:209.2034016<;>Creatinine_in_umol/L:67<;>Fibroblast_Growth_Factor_19_in_pg/ml:59.85<;>Glucagon-like_Peptide-1_in_pmol/L:0.6<;>Glucose_in_mg/dL:93.6936<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:16.4468289744<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:10.87<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:57.5639014104<;>Leptin_in_ug/L:18.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:865.49<;>Triglyceride_in_mg/dL:78.449956372	27.4	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260158	2106879392	20860192	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S398	S398	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.9<;>C-peptide_in_ng/ml:3.75375<;>Cholesterol_in_mg/dL:189.481824<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:97.11<;>Glucagon-like_Peptide-1_in_pmol/L:1.9<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:29.903325408<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.28<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:36.6315736248<;>Leptin_in_ug/L:33.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:763.23<;>Triglyceride_in_mg/dL:77.66545680828	24.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260159	2187599400	21659400	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S420	S420	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:21.6<;>C-peptide_in_ng/ml:2.01201<;>Cholesterol_in_mg/dL:270.3016224<;>Creatinine_in_umol/L:73<;>Fibroblast_Growth_Factor_19_in_pg/ml:109.15<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:99.099<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.165409732<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.37<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:71.46894772512<;>Leptin_in_ug/L:10.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:771.32<;>Triglyceride_in_mg/dL:79.23445593572	25.6	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260160	2333460974	23103574	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S421	S421	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:10.2<;>C-peptide_in_ng/ml:3.36336<;>Cholesterol_in_mg/dL:178.2675936<;>Creatinine_in_umol/L:56<;>Fibroblast_Growth_Factor_19_in_pg/ml:63.05<;>Glucagon-like_Peptide-1_in_pmol/L:1.3<;>Glucose_in_mg/dL:122.5224<;>Glycosylated_Hemoglobin_in_mmol/mol:105.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.23136103968<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.5<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:41.41610569008<;>Leptin_in_ug/L:49.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:109.75<;>Triglyceride_in_mg/dL:73.74295898968	44.6	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260161	4332127956	42892356	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S422	S422	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:8.45<;>C-peptide_in_ng/ml:1.89189<;>Cholesterol_in_mg/dL:135.34416<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:107.27<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:156.7566<;>Glycosylated_Hemoglobin_in_mmol/mol:114.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.32459381824<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.48<;>Interleukin_1_in_pg/ml:11.91<;>LDL_Particles_in_mg/dL:21.82942754784<;>Leptin_in_ug/L:21.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:804.95<;>Triglyceride_in_mg/dL:83.15695375432	25.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260162	6206585340	61451340	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S424	S424	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.78<;>C-peptide_in_ng/ml:4.41441<;>Cholesterol_in_mg/dL:232.4052576<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:782.18<;>Glucagon-like_Peptide-1_in_pmol/L:4.5<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:90.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.52072683456<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.53<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:54.27453561552<;>Leptin_in_ug/L:77.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):2.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1312.23<;>Triglyceride_in_mg/dL:128.65792845008	35.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260163	3218523570	31866570	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S432	S432	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:10.1<;>C-peptide_in_ng/ml:3.42342<;>Cholesterol_in_mg/dL:255.220416<;>Creatinine_in_umol/L:71<;>Fibroblast_Growth_Factor_19_in_pg/ml:100.73<;>Glucagon-like_Peptide-1_in_pmol/L:1.2<;>Glucose_in_mg/dL:97.2972<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.4371615152<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.2<;>Interleukin_1_in_pg/ml:2.73<;>LDL_Particles_in_mg/dL:61.89988359456<;>Leptin_in_ug/L:37.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1179.49<;>Triglyceride_in_mg/dL:203.18538700348	27.8	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260164	3528416012	34934812	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S434	S434	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:10.3<;>C-peptide_in_ng/ml:2.31231<;>Cholesterol_in_mg/dL:243.619488<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:374.99<;>Glucagon-like_Peptide-1_in_pmol/L:0.4<;>Glucose_in_mg/dL:136.9368<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.32459381824<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.23<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:60.25520069712<;>Leptin_in_ug/L:13.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:873.32<;>Triglyceride_in_mg/dL:123.95093106776	25.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260165	4665993960	46197960	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S436	S436	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:19.6<;>C-peptide_in_ng/ml:1.68168<;>Cholesterol_in_mg/dL:227.3781888<;>Creatinine_in_umol/L:81<;>Fibroblast_Growth_Factor_19_in_pg/ml:86.25<;>Glucagon-like_Peptide-1_in_pmol/L:0.2<;>Glucose_in_mg/dL:99.099<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:43.06078858752<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:11.82<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:39.02383965744<;>Leptin_in_ug/L:18.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1192.01<;>Triglyceride_in_mg/dL:67.46696247992	27.2	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260166	4395895316	43523716	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S439	S439	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.2<;>C-peptide_in_ng/ml:3.63363<;>Cholesterol_in_mg/dL:145.0116<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:49.3<;>Glucagon-like_Peptide-1_in_pmol/L:2.5<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.6605760024<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.85<;>Interleukin_1_in_pg/ml:16.85<;>LDL_Particles_in_mg/dL:24.22169358048<;>Leptin_in_ug/L:32.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:673.58<;>Triglyceride_in_mg/dL:50.9924716418	31.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260167	4349189684	43061284	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S441	S441	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.8<;>C-peptide_in_ng/ml:2.94294<;>Cholesterol_in_mg/dL:235.885536<;>Creatinine_in_umol/L:70<;>Fibroblast_Growth_Factor_19_in_pg/ml:102.69<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.38087766672<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2<;>Interleukin_1_in_pg/ml:9.56<;>LDL_Particles_in_mg/dL:61.3018170864<;>Leptin_in_ug/L:29.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:727.64<;>Triglyceride_in_mg/dL:99.63144459244	27.5	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260168	4677011242	46307042	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S446	S446	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	68	68	68	No	Adiponectin_in_ug/mL:15<;>C-peptide_in_ng/ml:2.91291<;>Cholesterol_in_mg/dL:174.4006176<;>Creatinine_in_umol/L:57<;>Fibroblast_Growth_Factor_19_in_pg/ml:119.19<;>Glucagon-like_Peptide-1_in_pmol/L:0.6<;>Glucose_in_mg/dL:158.5584<;>Glycosylated_Hemoglobin_in_mmol/mol:99<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.53039429376<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:38.95<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:36.33254037072<;>Leptin_in_ug/L:48.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:148.95<;>Triglyceride_in_mg/dL:112.18343761196	31.7	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260169	1920754976	19017376	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S451	S451	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:13.1<;>C-peptide_in_ng/ml:0.93093<;>Cholesterol_in_mg/dL:143.8515072<;>Creatinine_in_umol/L:58<;>Fibroblast_Growth_Factor_19_in_pg/ml:61.66<;>Glucagon-like_Peptide-1_in_pmol/L:1.7<;>Glucose_in_mg/dL:86.4864<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.76347624016<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.77<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:25.56734322384<;>Leptin_in_ug/L:2.17<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:660.47<;>Triglyceride_in_mg/dL:38.44047862228	20.4	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260170	3060202838	30299038	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S456	S456	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:26.3<;>C-peptide_in_ng/ml:1.92192<;>Cholesterol_in_mg/dL:247.0997664<;>Creatinine_in_umol/L:54<;>Fibroblast_Growth_Factor_19_in_pg/ml:155.23<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:84.6846<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:37.82770664112<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.9<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:53.37743585328<;>Leptin_in_ug/L:6.98<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:559.32<;>Triglyceride_in_mg/dL:49.42347251436	23.7	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260171	5829033604	57713204	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S457	S457	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:8.9<;>C-peptide_in_ng/ml:2.13213<;>Cholesterol_in_mg/dL:190.2552192<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:273.73<;>Glucagon-like_Peptide-1_in_pmol/L:0.4<;>Glucose_in_mg/dL:117.117<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:22.27797742896<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.21<;>Interleukin_1_in_pg/ml:5.77<;>LDL_Particles_in_mg/dL:42.76175533344<;>Leptin_in_ug/L:29.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:791.41<;>Triglyceride_in_mg/dL:98.84694502872	28.3	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260172	5463190394	54090994	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S458	S458	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:14.2<;>C-peptide_in_ng/ml:3.21321<;>Cholesterol_in_mg/dL:209.9767968<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:173.53<;>Glucagon-like_Peptide-1_in_pmol/L:4.6<;>Glucose_in_mg/dL:135.135<;>Glycosylated_Hemoglobin_in_mmol/mol:110<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:21.23136103968<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.53<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:40.51900592784<;>Leptin_in_ug/L:29.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:977.02<;>Triglyceride_in_mg/dL:225.93587435136	33	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260173	6016218318	59566518	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S462	S462	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.1<;>C-peptide_in_ng/ml:3.21321<;>Cholesterol_in_mg/dL:209.5900992<;>Creatinine_in_umol/L:57<;>Fibroblast_Growth_Factor_19_in_pg/ml:99.42<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:129.7296<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:18.24102849888<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.69<;>Interleukin_1_in_pg/ml:0.82<;>LDL_Particles_in_mg/dL:55.17163537776<;>Leptin_in_ug/L:25.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:556.64<;>Triglyceride_in_mg/dL:89.43295026408	29.4	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260174	4557287054	45121654	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S463	S463	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:6.1<;>C-peptide_in_ng/ml:3.18318<;>Cholesterol_in_mg/dL:165.5065728<;>Creatinine_in_umol/L:61<;>Fibroblast_Growth_Factor_19_in_pg/ml:48.04<;>Glucagon-like_Peptide-1_in_pmol/L:1.2<;>Glucose_in_mg/dL:120.7206<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.63329453152<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.48<;>Interleukin_1_in_pg/ml:1.42<;>LDL_Particles_in_mg/dL:32.74414132176<;>Leptin_in_ug/L:40.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:523.9<;>Triglyceride_in_mg/dL:123.16643150404	31	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260175	3201683234	31699834	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S468	S468	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Hungary	NCIT:C16699	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:14.2<;>C-peptide_in_ng/ml:1.83183<;>Cholesterol_in_mg/dL:208.0433088<;>Creatinine_in_umol/L:47<;>Fibroblast_Growth_Factor_19_in_pg/ml:123.71<;>Glucagon-like_Peptide-1_in_pmol/L:4.8<;>Glucose_in_mg/dL:133.3332<;>Glycosylated_Hemoglobin_in_mmol/mol:114.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.85670901872<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.38<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:48.29387053392<;>Leptin_in_ug/L:13<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:552.25<;>Triglyceride_in_mg/dL:38.44047862228	33.7	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260176	3742755384	37056984	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S470	S470	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:14.2<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:212.2969824<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:80.72<;>Glucagon-like_Peptide-1_in_pmol/L:0.5<;>Glucose_in_mg/dL:117.117<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.05284203504<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.34<;>Interleukin_1_in_pg/ml:12.89<;>LDL_Particles_in_mg/dL:48.29387053392<;>Leptin_in_ug/L:10.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:332.07<;>Triglyceride_in_mg/dL:43.1474760046	23.7	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260273	820824384	8550254	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S472	S472	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:12.7<;>C-peptide_in_ng/ml:2.97297<;>Cholesterol_in_mg/dL:199.149264<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:71.51<;>Glucagon-like_Peptide-1_in_pmol/L:0.5<;>Glucose_in_mg/dL:99.099<;>Glycosylated_Hemoglobin_in_mmol/mol:57.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:25.71685985088<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.52<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:40.66852255488<;>Leptin_in_ug/L:35.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:711.86<;>Triglyceride_in_mg/dL:122.38193194032	33.3	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260177	4335598114	42926714	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S475	S475	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Denmark	NCIT:C16496	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.11<;>C-peptide_in_ng/ml:1.38138<;>Cholesterol_in_mg/dL:205.3364256<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:54.88<;>Glucagon-like_Peptide-1_in_pmol/L:1.6<;>Glucose_in_mg/dL:154.9548<;>Glycosylated_Hemoglobin_in_mmol/mol:99<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:25.4178265968<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.69<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:48.74242041504<;>Leptin_in_ug/L:7.11<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.8<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:651.95<;>Triglyceride_in_mg/dL:61.97546553388	23	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260274	1145858688	11936028	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S476	S476	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:8.82<;>C-peptide_in_ng/ml:4.08408<;>Cholesterol_in_mg/dL:143.4648096<;>Creatinine_in_umol/L:55<;>Fibroblast_Growth_Factor_19_in_pg/ml:71.52<;>Glucagon-like_Peptide-1_in_pmol/L:8.9<;>Glucose_in_mg/dL:149.5494<;>Glycosylated_Hemoglobin_in_mmol/mol:101.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.88571139632<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.31<;>Interleukin_1_in_pg/ml:3.31<;>LDL_Particles_in_mg/dL:28.55767576464<;>Leptin_in_ug/L:21.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:902.35<;>Triglyceride_in_mg/dL:81.58795462688	30.2	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260178	5173989216	51227616	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S478	S478	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:12.3<;>C-peptide_in_ng/ml:2.04204<;>Cholesterol_in_mg/dL:146.1716928<;>Creatinine_in_umol/L:55<;>Fibroblast_Growth_Factor_19_in_pg/ml:63.13<;>Glucagon-like_Peptide-1_in_pmol/L:0.2<;>Glucose_in_mg/dL:135.135<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.96927671568<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.64<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:26.46444298608<;>Leptin_in_ug/L:43.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:970.13<;>Triglyceride_in_mg/dL:59.62196684272	36.6	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260179	4220008866	41782266	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S479	S479	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:10.7<;>C-peptide_in_ng/ml:4.11411<;>Cholesterol_in_mg/dL:221.9644224<;>Creatinine_in_umol/L:74<;>Fibroblast_Growth_Factor_19_in_pg/ml:149.5<;>Glucagon-like_Peptide-1_in_pmol/L:1.7<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.84876246624<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.78<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:46.05112112832<;>Leptin_in_ug/L:25.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:862.85<;>Triglyceride_in_mg/dL:279.28184468432	28.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260180	3226205832	31942632	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S483	S483	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:9.87<;>C-peptide_in_ng/ml:2.97297<;>Cholesterol_in_mg/dL:167.0533632<;>Creatinine_in_umol/L:67<;>Fibroblast_Growth_Factor_19_in_pg/ml:219.58<;>Glucagon-like_Peptide-1_in_pmol/L:3.1<;>Glucose_in_mg/dL:136.9368<;>Glycosylated_Hemoglobin_in_mmol/mol:94.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:31.3984916784<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.9<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:25.11879334272<;>Leptin_in_ug/L:28<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:578.9<;>Triglyceride_in_mg/dL:92.57094851896	23.7	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260181	5014212670	49645670	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S484	S484	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:6.48<;>C-peptide_in_ng/ml:4.14414<;>Cholesterol_in_mg/dL:227.3781888<;>Creatinine_in_umol/L:93<;>Fibroblast_Growth_Factor_19_in_pg/ml:59.25<;>Glucagon-like_Peptide-1_in_pmol/L:4.5<;>Glucose_in_mg/dL:115.3152<;>Glycosylated_Hemoglobin_in_mmol/mol:112.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.4371615152<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.21<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:56.66680164816<;>Leptin_in_ug/L:29.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1079.71<;>Triglyceride_in_mg/dL:138.07192321472	30.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260182	4418154706	43744106	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S485	S485	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.61<;>C-peptide_in_ng/ml:3.48348<;>Cholesterol_in_mg/dL:169.3735488<;>Creatinine_in_umol/L:70<;>Fibroblast_Growth_Factor_19_in_pg/ml:295.9<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:13.15746317952<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.58<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:44.854988112<;>Leptin_in_ug/L:15.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:717.03<;>Triglyceride_in_mg/dL:87.07945157292	23.4	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	96	96	ERR260275	1090824000	11362750	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S487	S487	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:10.9<;>C-peptide_in_ng/ml:1.62162<;>Cholesterol_in_mg/dL:172.8538272<;>Creatinine_in_umol/L:61<;>Fibroblast_Growth_Factor_19_in_pg/ml:544.12<;>Glucagon-like_Peptide-1_in_pmol/L:2.2<;>Glucose_in_mg/dL:86.4864<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.81976008864<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:99.22<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:37.08012350592<;>Leptin_in_ug/L:3.59<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:465.58<;>Triglyceride_in_mg/dL:57.26846815156	21.2	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260183	4621291764	45755364	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S488	S488	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:21.8<;>C-peptide_in_ng/ml:1.62162<;>Cholesterol_in_mg/dL:208.4300064<;>Creatinine_in_umol/L:70<;>Fibroblast_Growth_Factor_19_in_pg/ml:140.3<;>Glucagon-like_Peptide-1_in_pmol/L:0.2<;>Glucose_in_mg/dL:91.8918<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.6702434616<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.46<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:50.8356531936<;>Leptin_in_ug/L:7.28<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:356.51<;>Triglyceride_in_mg/dL:58.837467279	19.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260184	4346089994	43030594	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S495	S495	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Estonia	NCIT:C16562	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:9.52<;>C-peptide_in_ng/ml:3.9039<;>Cholesterol_in_mg/dL:336.8136096<;>Creatinine_in_umol/L:49<;>Fibroblast_Growth_Factor_19_in_pg/ml:228.33<;>Glucagon-like_Peptide-1_in_pmol/L:1.8<;>Glucose_in_mg/dL:124.3242<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.70719239168<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.23<;>Interleukin_1_in_pg/ml:1.44<;>LDL_Particles_in_mg/dL:87.4672268184<;>Leptin_in_ug/L:16.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:688.48<;>Triglyceride_in_mg/dL:164.7449083812	29.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260185	4266979118	42247318	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S497	S497	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.3<;>C-peptide_in_ng/ml:2.85285<;>Cholesterol_in_mg/dL:181.747872<;>Creatinine_in_umol/L:77<;>Fibroblast_Growth_Factor_19_in_pg/ml:176.5<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:142.3422<;>Glycosylated_Hemoglobin_in_mmol/mol:90.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.05284203504<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.81<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:37.22964013296<;>Leptin_in_ug/L:17<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:779.93<;>Triglyceride_in_mg/dL:34.51798080368	23.8	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260186	4022382974	39825574	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S51	S51	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:15.2<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:221.1910272<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:155.25<;>Glucagon-like_Peptide-1_in_pmol/L:1.2<;>Glucose_in_mg/dL:118.9188<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.06250949424<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.93<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:43.3598218416<;>Leptin_in_ug/L:14.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:254.49<;>Triglyceride_in_mg/dL:174.15890314584	28.8	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260187	2151950642	21306442	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S517	S517	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:8.91<;>C-peptide_in_ng/ml:2.52252<;>Cholesterol_in_mg/dL:209.2034016<;>Creatinine_in_umol/L:75<;>Fibroblast_Growth_Factor_19_in_pg/ml:172.73<;>Glucagon-like_Peptide-1_in_pmol/L:0.7<;>Glucose_in_mg/dL:99.099<;>Glycosylated_Hemoglobin_in_mmol/mol:101.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.02556056416<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.62<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:48.74242041504<;>Leptin_in_ug/L:25.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:704.4<;>Triglyceride_in_mg/dL:107.47644022964	27.5	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260188	4182939644	41415244	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S524	S524	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:10.7<;>C-peptide_in_ng/ml:2.01201<;>Cholesterol_in_mg/dL:192.1887072<;>Creatinine_in_umol/L:62<;>Fibroblast_Growth_Factor_19_in_pg/ml:76.65<;>Glucagon-like_Peptide-1_in_pmol/L:1.9<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.46444298608<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.37<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:40.21997267376<;>Leptin_in_ug/L:14.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:415.85<;>Triglyceride_in_mg/dL:88.64845070036	28.5	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260189	3682643416	36461816	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S526	S526	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:17.7<;>C-peptide_in_ng/ml:2.1021<;>Cholesterol_in_mg/dL:182.1345696<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:521.85<;>Glucagon-like_Peptide-1_in_pmol/L:5.9<;>Glucose_in_mg/dL:113.5134<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:33.34220782992<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.36<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:31.69752493248<;>Leptin_in_ug/L:14.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:510.36<;>Triglyceride_in_mg/dL:62.7599650976	26.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260190	4142624080	41016080	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S529	S529	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:4.39<;>C-peptide_in_ng/ml:1.95195<;>Cholesterol_in_mg/dL:132.2505792<;>Creatinine_in_umol/L:81<;>Glucose_in_mg/dL:255.8556<;>Glycosylated_Hemoglobin_in_mmol/mol:169.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:19.88571139632<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.85<;>LDL_Particles_in_mg/dL:20.33426127744<;>Leptin_in_ug/L:32.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Triglyceride_in_mg/dL:127.08892932264	27.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260191	4948806686	48998086	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin;Insulin	NCIT:C61612;CHEBI:87631;NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S53	S53	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:12<;>C-peptide_in_ng/ml:1.5015<;>Cholesterol_in_mg/dL:207.6566112<;>Creatinine_in_umol/L:76<;>Glucose_in_mg/dL:75.6756<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.37121020752<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.25<;>LDL_Particles_in_mg/dL:48.89193704208<;>Leptin_in_ug/L:5.28<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Triglyceride_in_mg/dL:80.80345506316	21.3	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260193	2822317336	27943736	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S530	S530	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.8<;>C-peptide_in_ng/ml:0.87087<;>Cholesterol_in_mg/dL:225.4447008<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:255.56<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:154.9548<;>Glycosylated_Hemoglobin_in_mmol/mol:123.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.96927671568<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.08<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:57.41438478336<;>Leptin_in_ug/L:14.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1061.43<;>Triglyceride_in_mg/dL:55.69946902412	28.1	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260192	3860516334	38222934	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;Insulin	NCIT:C61612;NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S536	S536	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.17<;>C-peptide_in_ng/ml:3.33333<;>Cholesterol_in_mg/dL:174.7873152<;>Creatinine_in_umol/L:55<;>Fibroblast_Growth_Factor_19_in_pg/ml:54.12<;>Glucagon-like_Peptide-1_in_pmol/L:3.5<;>Glucose_in_mg/dL:153.153<;>Glycosylated_Hemoglobin_in_mmol/mol:105.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:15.84876246624<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:4.91<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:30.94994179728<;>Leptin_in_ug/L:12.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:764.42<;>Triglyceride_in_mg/dL:240.84136606204	33	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260194	4292398798	42498998	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;statin	NCIT:C61612;CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S54	S54	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:11.9<;>C-peptide_in_ng/ml:1.5015<;>Cholesterol_in_mg/dL:156.2258304<;>Creatinine_in_umol/L:72<;>Glucose_in_mg/dL:91.8918<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:37.82770664112<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.99<;>LDL_Particles_in_mg/dL:18.68957838<;>Leptin_in_ug/L:3.92<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Triglyceride_in_mg/dL:45.50097469576	21.1	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260195	2739388862	27122662	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S543	S543	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:10.5<;>C-peptide_in_ng/ml:3.6036<;>Cholesterol_in_mg/dL:177.880896<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:137.13<;>Glucagon-like_Peptide-1_in_pmol/L:1.3<;>Glucose_in_mg/dL:129.7296<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.10912588352<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:7.93<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:33.79075771104<;>Leptin_in_ug/L:31.8<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1203.67<;>Triglyceride_in_mg/dL:80.80345506316	27.6	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260196	4253796800	42116800	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S547	S547	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:7.3<;>C-peptide_in_ng/ml:2.64264<;>Cholesterol_in_mg/dL:216.1639584<;>Creatinine_in_umol/L:64<;>Glucose_in_mg/dL:86.4864<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.22169358048<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.64<;>LDL_Particles_in_mg/dL:51.43371970176<;>Leptin_in_ug/L:20.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Triglyceride_in_mg/dL:94.1399476464	24.3	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260197	4151530058	41104258	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S550	S550	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.29<;>C-peptide_in_ng/ml:1.02102<;>Cholesterol_in_mg/dL:186.0015456<;>Creatinine_in_umol/L:89<;>Fibroblast_Growth_Factor_19_in_pg/ml:126.98<;>Glucagon-like_Peptide-1_in_pmol/L:3.3<;>Glucose_in_mg/dL:162.162<;>Glycosylated_Hemoglobin_in_mmol/mol:129.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:13.75552968768<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:12.36<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:35.73447386256<;>Leptin_in_ug/L:57.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1319.38<;>Triglyceride_in_mg/dL:261.23835471876	22.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	96	96	ERR260276	996047040	10375490	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin;Insulin	CHEBI:87631;NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S551	S551	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:18.3<;>C-peptide_in_ng/ml:2.85285<;>Cholesterol_in_mg/dL:233.1786528<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:73.08<;>Glucagon-like_Peptide-1_in_pmol/L:2.1<;>Glucose_in_mg/dL:129.7296<;>Glycosylated_Hemoglobin_in_mmol/mol:96.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:49.3404869232<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.62<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:34.3888242192<;>Leptin_in_ug/L:5.49<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:901.43<;>Triglyceride_in_mg/dL:76.09645768084	21.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260198	4760622880	47134880	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S552	S552	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:15.1<;>C-peptide_in_ng/ml:2.49249<;>Cholesterol_in_mg/dL:206.4965184<;>Creatinine_in_umol/L:50<;>Fibroblast_Growth_Factor_19_in_pg/ml:113.79<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:108.108<;>Glycosylated_Hemoglobin_in_mmol/mol:90.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:32.59462469472<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:5.21<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.46272207936<;>Leptin_in_ug/L:12.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:889.54<;>Triglyceride_in_mg/dL:54.9149694604	19.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260199	3032782146	30027546	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S558	S558	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:18.8<;>C-peptide_in_ng/ml:2.13213<;>Cholesterol_in_mg/dL:205.3364256<;>Creatinine_in_umol/L:58<;>Glucose_in_mg/dL:131.5314<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:38.27625652224<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.1<;>LDL_Particles_in_mg/dL:35.8839904896<;>Leptin_in_ug/L:22.9<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Triglyceride_in_mg/dL:61.97546553388	25.5	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260200	3556340694	35211294	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S561	S561	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:16.3<;>C-peptide_in_ng/ml:3.96396<;>Cholesterol_in_mg/dL:152.745552<;>Creatinine_in_umol/L:74<;>Fibroblast_Growth_Factor_19_in_pg/ml:315.21<;>Glucagon-like_Peptide-1_in_pmol/L:4.5<;>Glucose_in_mg/dL:79.2792<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:4.4854988112<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:27.15<;>Interleukin_1_in_pg/ml:2.23<;>LDL_Particles_in_mg/dL:42.91127196048<;>Leptin_in_ug/L:10.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:2276.46<;>Triglyceride_in_mg/dL:136.50292408728	21.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260201	4322020280	42792280	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S563	S563	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Finland	NCIT:C16584	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:4.69<;>C-peptide_in_ng/ml:5.16516<;>Cholesterol_in_mg/dL:151.5854592<;>Creatinine_in_umol/L:68<;>Fibroblast_Growth_Factor_19_in_pg/ml:16.4<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:236.0358<;>Glycosylated_Hemoglobin_in_mmol/mol:138.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.48377790448<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.33<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:22.72652731008<;>Leptin_in_ug/L:36.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.7<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1798.27<;>Triglyceride_in_mg/dL:180.4348996556	29.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260202	3464254550	34299550	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin;Insulin	NCIT:C61612;NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S577	S577	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:8.67<;>C-peptide_in_ng/ml:3.33333<;>Cholesterol_in_mg/dL:248.6465568<;>Creatinine_in_umol/L:67<;>Fibroblast_Growth_Factor_19_in_pg/ml:62.57<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:117.117<;>Glycosylated_Hemoglobin_in_mmol/mol:94.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.6702434616<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.38<;>Interleukin_1_in_pg/ml:6.65<;>LDL_Particles_in_mg/dL:59.806650816<;>Leptin_in_ug/L:31.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:890.01<;>Triglyceride_in_mg/dL:135.71842452356	26.6	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260203	2859467358	28311558	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S58	S58	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Iceland	NCIT:C16704	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:9.7<;>C-peptide_in_ng/ml:2.55255<;>Cholesterol_in_mg/dL:213.0703776<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:56.47<;>Glucagon-like_Peptide-1_in_pmol/L:1.2<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:27.81009262944<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:13.16<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:47.39677077168<;>Leptin_in_ug/L:44<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1184.81<;>Triglyceride_in_mg/dL:84.72595288176	31.9	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260204	2669086600	26426600	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S584	S584	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.9<;>C-peptide_in_ng/ml:1.89189<;>Cholesterol_in_mg/dL:228.5382816<;>Creatinine_in_umol/L:89<;>Glucose_in_mg/dL:84.6846<;>Glycosylated_Hemoglobin_in_mmol/mol:70.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.94994179728<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.86<;>LDL_Particles_in_mg/dL:49.04145366912<;>Leptin_in_ug/L:5.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.7<;>Triglyceride_in_mg/dL:96.49344633756	21.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260205	3029874356	29998756	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S587	S587	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	C-peptide_in_ng/ml:0.36036<;>Cholesterol_in_mg/dL:137.6643456<;>Creatinine_in_umol/L:63<;>Glucose_in_mg/dL:84.6846<;>Glycosylated_Hemoglobin_in_mmol/mol:143<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.94994179728<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.06<;>LDL_Particles_in_mg/dL:17.79247861776<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):2.2<;>Triglyceride_in_mg/dL:51.77697120552	27.5	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260206	2766721482	27393282	23719380	IlluminaHiSeq	Female	NCIT:C16576	Insulin	NCIT:C2271	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S589	S589	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Germany	NCIT:C16636	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:3.68<;>C-peptide_in_ng/ml:4.14414<;>Cholesterol_in_mg/dL:264.1144608<;>Creatinine_in_umol/L:75<;>Fibroblast_Growth_Factor_19_in_pg/ml:109.28<;>Glucagon-like_Peptide-1_in_pmol/L:17.8<;>Glucose_in_mg/dL:138.7386<;>Glycosylated_Hemoglobin_in_mmol/mol:107.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:18.83909500704<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.54<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:69.67474820064<;>Leptin_in_ug/L:31.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1169.62<;>Triglyceride_in_mg/dL:157.68441230772	29	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260207	3170606746	31392146	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S59	S59	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:19<;>C-peptide_in_ng/ml:1.23123<;>Cholesterol_in_mg/dL:208.816704<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:89.17<;>Glucagon-like_Peptide-1_in_pmol/L:0.4<;>Glucose_in_mg/dL:97.2972<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:49.3404869232<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.34<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:26.165409732<;>Leptin_in_ug/L:3.58<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:675.62<;>Triglyceride_in_mg/dL:61.19096597016	18.2	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260209	2516923030	24920030	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S591	S591	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:14.5<;>C-peptide_in_ng/ml:2.76276<;>Cholesterol_in_mg/dL:191.0286144<;>Creatinine_in_umol/L:77<;>Fibroblast_Growth_Factor_19_in_pg/ml:199.62<;>Glucagon-like_Peptide-1_in_pmol/L:3.1<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.05284203504<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.81<;>Interleukin_1_in_pg/ml:0.63<;>LDL_Particles_in_mg/dL:36.48205699776<;>Leptin_in_ug/L:21.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:434.41<;>Triglyceride_in_mg/dL:85.51045244548	25	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260208	3833173412	37952212	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S598	S598	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:12.3<;>C-peptide_in_ng/ml:3.42342<;>Cholesterol_in_mg/dL:149.6519712<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:82.18<;>Glucagon-like_Peptide-1_in_pmol/L:3.3<;>Glucose_in_mg/dL:126.126<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:25.71685985088<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.29<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:25.56734322384<;>Leptin_in_ug/L:53.6<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:822.75<;>Triglyceride_in_mg/dL:75.31195811712	29.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260210	3514734754	34799354	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S60	S60	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:7.34<;>C-peptide_in_ng/ml:2.79279<;>Cholesterol_in_mg/dL:211.9102848<;>Creatinine_in_umol/L:53<;>Fibroblast_Growth_Factor_19_in_pg/ml:99.15<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:100.9008<;>Glycosylated_Hemoglobin_in_mmol/mol:88<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.62362707232<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:4.55<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:53.37743585328<;>Leptin_in_ug/L:49.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:966.14<;>Triglyceride_in_mg/dL:57.26846815156	27.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR275251	3014779704	29849304	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S600	S600	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:12.1<;>C-peptide_in_ng/ml:2.82282<;>Cholesterol_in_mg/dL:159.3194112<;>Creatinine_in_umol/L:76<;>Glucose_in_mg/dL:115.3152<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:23.32459381824<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.53<;>LDL_Particles_in_mg/dL:30.20235866208<;>Leptin_in_ug/L:21.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):1.2<;>Triglyceride_in_mg/dL:94.1399476464	24.8	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260211	3105065624	30743224	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S602	S602	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:6.43<;>C-peptide_in_ng/ml:4.74474<;>Cholesterol_in_mg/dL:189.8685216<;>Creatinine_in_umol/L:61<;>Fibroblast_Growth_Factor_19_in_pg/ml:131.9<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:117.117<;>Glycosylated_Hemoglobin_in_mmol/mol:92.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:20.03522802336<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.54<;>Interleukin_1_in_pg/ml:1.74<;>LDL_Particles_in_mg/dL:44.55595485792<;>Leptin_in_ug/L:34.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:765.62<;>Triglyceride_in_mg/dL:102.76944284732	30	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR275252	3603680606	35680006	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S604	S604	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Slovakia	NCIT:C17669	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:11.7<;>C-peptide_in_ng/ml:7.8078<;>Cholesterol_in_mg/dL:271.0750176<;>Creatinine_in_umol/L:90<;>Fibroblast_Growth_Factor_19_in_pg/ml:253.37<;>Glucagon-like_Peptide-1_in_pmol/L:16<;>Glucose_in_mg/dL:297.297<;>Glycosylated_Hemoglobin_in_mmol/mol:129.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:18.98861163408<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:6.25<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:63.84359974608<;>Leptin_in_ug/L:36.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1348.58<;>Triglyceride_in_mg/dL:257.31585690016	28.9	Paolo_Manghi;Marisa_Metzger	Type 2 Diabetes Mellitus	NCIT:C26747	101	101	ERR260214	3923443172	38845972	23719380	IlluminaHiSeq	Female	NCIT:C16576	Metformin	NCIT:C61612	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S614	S614	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:28<;>C-peptide_in_ng/ml:1.92192<;>Cholesterol_in_mg/dL:260.6341824<;>Creatinine_in_umol/L:66<;>Fibroblast_Growth_Factor_19_in_pg/ml:158.25<;>Glucagon-like_Peptide-1_in_pmol/L:1.7<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:39.17335628448<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.94<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:55.3211520048<;>Leptin_in_ug/L:12.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1224.79<;>Triglyceride_in_mg/dL:71.38946029852	20.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260215	1545961348	15306548	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S617	S617	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:14.8<;>C-peptide_in_ng/ml:2.19219<;>Cholesterol_in_mg/dL:226.218096<;>Creatinine_in_umol/L:76<;>Fibroblast_Growth_Factor_19_in_pg/ml:168.9<;>Glucagon-like_Peptide-1_in_pmol/L:1.4<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:81.4<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:22.87604393712<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.04<;>Interleukin_1_in_pg/ml:6<;>LDL_Particles_in_mg/dL:58.3114845456<;>Leptin_in_ug/L:15.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:655.61<;>Triglyceride_in_mg/dL:72.17395986224	23.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260216	979554560	9698560	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S618	S618	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:11.8<;>C-peptide_in_ng/ml:1.98198<;>Cholesterol_in_mg/dL:221.5777248<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:54.27<;>Glucagon-like_Peptide-1_in_pmol/L:0.9<;>Glucose_in_mg/dL:93.6936<;>Glycosylated_Hemoglobin_in_mmol/mol:72.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:25.56734322384<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.09<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:52.330819464<;>Leptin_in_ug/L:12.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.1<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:333.52<;>Triglyceride_in_mg/dL:90.2174498278	21.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260217	1699498114	16826714	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S628	S628	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:11.9<;>C-peptide_in_ng/ml:1.59159<;>Cholesterol_in_mg/dL:235.1121408<;>Creatinine_in_umol/L:44<;>Fibroblast_Growth_Factor_19_in_pg/ml:67.19<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:95.4954<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:34.98689072736<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:14.92<;>Interleukin_1_in_pg/ml:0.63<;>LDL_Particles_in_mg/dL:51.28420307472<;>Leptin_in_ug/L:21.3<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:913.25<;>Triglyceride_in_mg/dL:53.34597033296	25.8	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260218	1397757180	13839180	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S638	S638	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:10.5<;>C-peptide_in_ng/ml:1.65165<;>Cholesterol_in_mg/dL:257.153904<;>Creatinine_in_umol/L:60<;>Fibroblast_Growth_Factor_19_in_pg/ml:306.87<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:104.5044<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:41.71513894416<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.26<;>Interleukin_1_in_pg/ml:2.05<;>LDL_Particles_in_mg/dL:53.37743585328<;>Leptin_in_ug/L:8.12<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:690.95<;>Triglyceride_in_mg/dL:49.42347251436	22.4	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260219	1153977722	11425522	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S640	S640	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:14.4<;>C-peptide_in_ng/ml:2.25225<;>Cholesterol_in_mg/dL:186.0015456<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:55.88<;>Glucagon-like_Peptide-1_in_pmol/L:1<;>Glucose_in_mg/dL:118.9188<;>Glycosylated_Hemoglobin_in_mmol/mol:74.8<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:41.41610569008<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.71<;>Interleukin_1_in_pg/ml:1.02<;>LDL_Particles_in_mg/dL:24.81976008864<;>Leptin_in_ug/L:13.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.6<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:567.92<;>Triglyceride_in_mg/dL:65.89796335248	25	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260220	2557243442	25319242	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S643	S643	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:34.8<;>C-peptide_in_ng/ml:1.53153<;>Cholesterol_in_mg/dL:202.6295424<;>Creatinine_in_umol/L:59<;>Fibroblast_Growth_Factor_19_in_pg/ml:220.89<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:79.2<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:30.80042517024<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.77<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:42.76175533344<;>Leptin_in_ug/L:10.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:867.17<;>Triglyceride_in_mg/dL:55.69946902412	27.4	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260221	1546072246	15307646	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S646	S646	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Case	NCIT_C49152	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:7.49<;>C-peptide_in_ng/ml:3.75375<;>Cholesterol_in_mg/dL:170.5336416<;>Creatinine_in_umol/L:64<;>Fibroblast_Growth_Factor_19_in_pg/ml:188.26<;>Glucagon-like_Peptide-1_in_pmol/L:1.5<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:12.85842992544<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.4<;>Interleukin_1_in_pg/ml:0<;>LDL_Particles_in_mg/dL:39.32287291152<;>Leptin_in_ug/L:23.4<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.3<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:585.88<;>Triglyceride_in_mg/dL:160.03791099888	31.9	Paolo_Manghi;Marisa_Metzger	Glucose Intolerance	NCIT:C34646	101	101	ERR260222	1435723080	14215080	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S655	S655	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	71	71	71	No	Adiponectin_in_ug/mL:11.7<;>C-peptide_in_ng/ml:1.65165<;>Cholesterol_in_mg/dL:208.4300064<;>Creatinine_in_umol/L:72<;>Fibroblast_Growth_Factor_19_in_pg/ml:120.59<;>Glucagon-like_Peptide-1_in_pmol/L:0.3<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.76347624016<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:3.52<;>Interleukin_1_in_pg/ml:1.65<;>LDL_Particles_in_mg/dL:47.99483727984<;>Leptin_in_ug/L:15.1<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:464.81<;>Triglyceride_in_mg/dL:69.03596160736	27.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260223	1266123274	12535874	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S77	S77	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:24.8<;>C-peptide_in_ng/ml:2.43243<;>Cholesterol_in_mg/dL:241.2993024<;>Creatinine_in_umol/L:63<;>Fibroblast_Growth_Factor_19_in_pg/ml:72<;>Glucagon-like_Peptide-1_in_pmol/L:0.1<;>Glucose_in_mg/dL:99.099<;>Glycosylated_Hemoglobin_in_mmol/mol:94.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:26.01589310496<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.69<;>Interleukin_1_in_pg/ml:0.6<;>LDL_Particles_in_mg/dL:63.544566492<;>Leptin_in_ug/L:28.5<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.5<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1006.04<;>Triglyceride_in_mg/dL:43.1474760046	33.2	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260224	2765273748	27378948	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S80	S80	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	70	70	70	No	Adiponectin_in_ug/mL:11.3<;>C-peptide_in_ng/ml:2.43243<;>Cholesterol_in_mg/dL:209.2034016<;>Creatinine_in_umol/L:69<;>Fibroblast_Growth_Factor_19_in_pg/ml:100.14<;>Glucagon-like_Peptide-1_in_pmol/L:1.1<;>Glucose_in_mg/dL:106.3062<;>Glycosylated_Hemoglobin_in_mmol/mol:77<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:24.07217695344<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:0.83<;>Interleukin_1_in_pg/ml:0.14<;>LDL_Particles_in_mg/dL:47.0977375176<;>Leptin_in_ug/L:28.2<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.4<;>Scavenger_Receptor_Cysteine-Rich_Type_1_Protein_M130_in_ng/ml:1163.37<;>Triglyceride_in_mg/dL:112.96793717568	27.5	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260225	1880622222	18620022	23719380	IlluminaHiSeq	Female	NCIT:C16576	statin	CHEBI:87631	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S88	S88	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:19<;>C-peptide_in_ng/ml:1.74174<;>Cholesterol_in_mg/dL:214.617168<;>Creatinine_in_umol/L:63<;>Glucose_in_mg/dL:102.7026<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:32.8936579488<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:2.98<;>LDL_Particles_in_mg/dL:44.854988112<;>Leptin_in_ug/L:7.14<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.2<;>Triglyceride_in_mg/dL:61.19096597016	21.1	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260226	2757221826	27299226	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
KarlssonFH_2013	S92	S92	Glucose Intolerance;Type 2 Diabetes Mellitus	NCIT:C34646;NCIT:C26747	Study Control	NCIT_C142703	Sweden	NCIT:C17180	feces	UBERON:0001988	Elderly	NCIT:C16268	69	69	69	No	Adiponectin_in_ug/mL:17.8<;>C-peptide_in_ng/ml:2.16216<;>Cholesterol_in_mg/dL:235.885536<;>Creatinine_in_umol/L:70<;>Glucose_in_mg/dL:90.09<;>Glycosylated_Hemoglobin_in_mmol/mol:83.6<;>High_Density_Lipoprotein_Cholesterol_in_mg/dL:28.4081591376<;>High_Sensitivity_C-Reactive_Protein_in_mg/L:1.02<;>LDL_Particles_in_mg/dL:55.76970188592<;>Leptin_in_ug/L:14.7<;>Measurement_of_glutamate_decarboxylase_65_antibody_(procedure):0.9<;>Triglyceride_in_mg/dL:80.80345506316	22.6	Paolo_Manghi;Marisa_Metzger	Healthy	NCIT:C115935	101	101	ERR260227	2215989086	21940486	23719380	IlluminaHiSeq	Female	NCIT:C16576	None	NCIT:C41132	Yes	cMD	2025-07-13 16:10:43.046834
